Phone: (832) 667-5811
Methodist DeBakey Heart Center researchers present at American College of Cardiology Scientific SessHouston, TX - 3/8/2006
Research and expertise from Methodist DeBakey Heart Center (MDHC) cardiologists will be highlighted in more than 25 talks at the 2006 American College of Cardiology Scientific Sessions, one of cardiology’s biggest conferences of the year.
Topics range from advanced cardiac diagnostic imaging to novel therapies for heart failure to new treatments for conditions such as ischemic heart disease, atrial fibrillation and valvular heart disease, among others.
"This conference is an exceptional forum to share new ideas in research with our peers across the nation and around the world," said Miguel A. Quiñones, M.D., FACC, chair of the department of cardiology at The Methodist Hospital and medical director of the Methodist DeBakey Heart Center. "We look forward to sharing our research findings and a having meaningful discussions with colleagues from other institutions as we prepare our research for presentation at the American College of Cardiology Scientific Sessions."
Four sessions at the prestigious conference will be co-chaired by MDHC cardiologists, William A. Zoghbi, M.D., FACC, medical director of cardiovascular imaging at Methodist, Guillermo Torre-Amione, M.D., FACC, medical director of the heart transplant service at Methodist, Neal S. Kleiman, M.D., FACC, medical director of the cardiac catheterization laboratory at Methodist, and John J. Mahmarian, M.D., FACC, medical director of nuclear cardiology at Methodist.
Methodist DeBakey Heart Center researchers and cardiologists collaborate with The Methodist Hospital Research Institute in pioneering research in areas such as advanced heart failure/transplant, atherosclerosis, preventive cardiology, cardiovascular surgery, echocardiography, genetics, proteomics, interventional cardiology, nuclear cardiology and vascular surgery.
Presentations given by MDHC physicians at this year’s ACC represent six primary areas of research: advanced heart failure, ischemic heart disease, arrhythmia therapy, valvular heart disease, vascular disease and atherosclerosis, and metabolic syndrome and diabetes.